| 1 | Infliximab for the treatment of fistulas in patients with Crohn's disease. Present DH · 1999 · N Engl J Med | | 2,135 |
| 2 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Lamb · 2019 · Gut | | 1,838 |
| 3 | Infliximab maintenance therapy for fistulizing Crohn's disease. Sands BE · 2004 · N Engl J Med | | 1,716 |
| 4 | 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management. Gomollón F · 2017 · J Crohns Colitis | | 1,567 |
| 5 | Inflammatory bowel disease: clinical aspects and established and evolving therapies Baumgart · 2007 · Lancet | | 1,444 |
| 6 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. 2010 · J Crohns Colitis | | 1,107 |
| 7 | ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment. Torres J · 2020 · J Crohns Colitis | | 1,097 |
| 8 | The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Greenstein · 1976 · Medicine (Baltimore) | | 1,063 |
| 9 | Ileal pouch-anal anastomoses complications and function in 1005 patients Fazio · 1995 · Ann Surg | | 959 |
| 10 | Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Shi Y · 2018 · Nat Rev Nephrol | | 930 |
| 11 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. 2010 · J Crohns Colitis | | 857 |
| 12 | Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Panés J · 2016 · Lancet | | 821 |
| 13 | Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. Ruemmele FM · 2014 · J Crohns Colitis | | 815 |
| 14 | The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Schwartz DA · 2002 · Gastroenterology | | 801 |
| 15 | Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics Sartor · 2004 · Gastroenterology | | 758 |
| 16 | Predictors of Crohn's disease. Beaugerie L · 2006 · Gastroenterology | | 714 |
| 17 | Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. D'Haens · 1998 · Gastroenterology | | 682 |
| 18 | Mesenchymal stem cells: mechanisms of inflammation. Singer NG · 2011 · Annu Rev Pathol | | 661 |
| 19 | Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Ng SC · 2013 · Gastroenterology | | 650 |
| 20 | Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Thia KT · 2010 · Gastroenterology | | 639 |
| 21 | Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Rutgeerts · 1991 · Lancet | | 598 |
| 22 | A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. García-Olmo D · 2005 · Dis Colon Rectum | | 587 |
| 23 | 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. Gionchetti P · 2017 · J Crohns Colitis | | 579 |
| 24 | Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Garcia-Olmo D · 2009 · Dis Colon Rectum | | 573 |
| 25 | The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update. van Rheenen PF · 2021 · J Crohns Colitis | | 552 |
| 26 | Risk factors for surgery and postoperative recurrence in Crohn's disease. Bernell O · 2000 · Ann Surg | | 517 |
| 27 | Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Worthey EA · 2011 · Genet Med | | 516 |
| 28 | Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. González MA · 2009 · Gastroenterology | | 503 |
| 29 | Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Peyrin-Biroulet L · 2008 · Clin Gastroenterol Hepatol | | 482 |
| 30 | Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Lichtenstein GR · 2005 · Gastroenterology | | 470 |
| 31 | Biological functions of mesenchymal stem cells and clinical implications. Naji A · 2019 · Cell Mol Life Sci | | 443 |
| 32 | National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Rankin GB · 1979 · Gastroenterology | | 443 |
| 33 | AGA technical review on perianal Crohn's disease. Sandborn WJ · 2003 · Gastroenterology | | 441 |
| 34 | Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Ciccocioppo R · 2011 · Gut | | 440 |
| 35 | Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Farmer RG · 1985 · Gastroenterology | | 428 |
| 36 | ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment. Adamina M · 2020 · J Crohns Colitis | | 426 |
| 37 | European evidence based consensus on the diagnosis and management of Crohn's disease: current management. 2006 · Gut | | 421 |
| 38 | Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Khan KJ · 2011 · Am J Gastroenterol | | 399 |
| 39 | Evidence-based clinical practice guidelines for inflammatory bowel disease Matsuoka · 2018 · J Gastroenterol | | 398 |
| 40 | Metronidazole therapy for perineal Crohn's disease: a follow-up study. Brandt LJ · 1982 · Gastroenterology | | 395 |
| 41 | A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale. Clifford GM · 2021 · Int J Cancer | | 393 |
| 42 | Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition Turner · 2018 · J Pediatr Gastroenterol Nutr | | 387 |
| 43 | A comprehensive review and update on Crohn's disease. Gajendran M · 2018 · Dis Mon | | 382 |
| 44 | Crohn Disease: Epidemiology, Diagnosis, and Management. Feuerstein JD · 2017 · Mayo Clin Proc | | 374 |
| 45 | Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Sandborn WJ · 1999 · Inflamm Bowel Dis | | 370 |
| 46 | Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Hellers · 1980 · Gut | | 364 |
| 47 | The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Nguyen GC · 2016 · Gastroenterology | | 360 |
| 48 | Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease. Panés J · 2018 · Gastroenterology | | 355 |
| 49 | The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? D'Haens GR · 2011 · Am J Gastroenterol | | 354 |
| 50 | A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Schwartz DA · 2001 · Gastroenterology | | 352 |
| 51 | Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. Bousvaros · 2007 · J Pediatr Gastroenterol Nutr | | 351 |
| 52 | Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. Peyrin-Biroulet L · 2016 · Clin Gastroenterol Hepatol | | 346 |
| 53 | Clinical features and natural history of Crohn's disease. Mekhjian HS · 1979 · Gastroenterology | | 345 |
| 54 | AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. Feuerstein JD · 2021 · Gastroenterology | | 338 |
| 55 | Optimizing anti-TNF treatment in inflammatory bowel disease. Rutgeerts P · 2004 · Gastroenterology | | 327 |
| 56 | Healing of perineal Crohn's disease with metronidazole. Bernstein LH · 1980 · Gastroenterology | | 326 |
| 57 | Chronic ulcerative colitis and colorectal cancer Rogler · 2014 · Cancer Lett | | 321 |
| 58 | Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment Sandborn · 1994 · Gastroenterology | | 319 |
| 59 | Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Jess · 2007 · Inflamm Bowel Dis | | 316 |
| 60 | Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Nguyen GC · 2008 · Am J Gastroenterol | | 312 |
| 61 | A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease. Gecse KB · 2014 · Gut | | 305 |
| 62 | Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Van Assche G · 2003 · Am J Gastroenterol | | 300 |
| 63 | Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis Hahnloser · 2007 · Br J Surg | | 297 |
| 64 | ECCO-ESCP Consensus on Surgery for Crohn's Disease Bemelman · 2018 · J Crohns Colitis | | 290 |
| 65 | European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. 2006 · Gut | | 288 |
| 66 | Assessing response and loss of response to biological therapies in IBD. Yanai H · 2011 · Am J Gastroenterol | | 283 |
| 67 | Review article: the natural history of postoperative Crohn's disease recurrence. Buisson A · 2012 · Aliment Pharmacol Ther | | 283 |
| 68 | Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial. Ponsioen CY · 2017 · Lancet Gastroenterol Hepatol | | 276 |
| 69 | Hidradenitis suppurativa. Revuz J · 2009 · J Eur Acad Dermatol Venereol | | 276 |
| 70 | Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease. 2018 · Radiology | | 276 |
| 71 | Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Bernell O · 2000 · Br J Surg | | 273 |
| 72 | The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium. Dulai PS · 2016 · Am J Gastroenterol | | 270 |
| 73 | Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial. de la Portilla F · 2013 · Int J Colorectal Dis | | 268 |
| 74 | Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. Irvine EJ · 1995 · J Clin Gastroenterol | | 267 |
| 75 | Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial. Ehrenpreis ED · 1999 · Gastroenterology | | 266 |
| 76 | Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease. Molendijk I · 2015 · Gastroenterology | | 260 |
| 77 | ECCO Guidelines on Inflammatory Bowel Disease and Malignancies. 2023 · J Crohns Colitis | | 258 |
| 78 | Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. Yarur AJ · 2017 · Aliment Pharmacol Ther | | 252 |
| 79 | Recent developments in "nonspecific" inflammatory bowel disease (first of two parts). Kirsner · 1982 · N Engl J Med | | 251 |
| 80 | Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study. Sands BE · 2004 · Clin Gastroenterol Hepatol | | 250 |
| 81 | Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Farrokhyar F · 2006 · Inflamm Bowel Dis | | 248 |
| 82 | Long-term failure after restorative proctocolectomy for ulcerative colitis Tulchinsky · 2003 · Ann Surg | | 243 |
| 83 | Ulcerative colitis as a progressive disease: the forgotten evidence. Torres J · 2012 · Inflamm Bowel Dis | | 241 |
| 84 | Predictors of severe Crohn's disease. Loly C · 2008 · Scand J Gastroenterol | | 241 |
| 85 | Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients. Ricart E · 2001 · Am J Gastroenterol | | 236 |
| 86 | Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Sandborn WJ · 2003 · Gastroenterology | | 235 |
| 87 | Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Korelitz BI · 1985 · Dig Dis Sci | | 232 |
| 88 | Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. García-Olmo D · 2003 · Int J Colorectal Dis | | 230 |
| 89 | Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project. Cleynen I · 2013 · Gut | | 230 |
| 90 | Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Cosnes J · 2013 · Gastroenterology | | 228 |
| 91 | Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Riekstina U · 2009 · Stem Cell Rev Rep | | 225 |
| 92 | Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Nguyen GC · 2006 · Am J Gastroenterol | | 224 |
| 93 | Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Neut · 2002 · Am J Gastroenterol | | 220 |
| 94 | Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap. Sonoda · 2002 · Dis Colon Rectum | | 219 |
| 95 | Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Malgieri A · 2010 · Int J Clin Exp Med | | 218 |
| 96 | Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy. Panés J · 2017 · Nat Rev Gastroenterol Hepatol | | 218 |
| 97 | Endorectal advancement flap: are there predictors of failure? Mizrahi · 2002 · Dis Colon Rectum | | 217 |
| 98 | Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula. Lee WY · 2013 · Stem Cells | | 216 |
| 99 | Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease. Ungaro RC · 2020 · Gastroenterology | | 216 |
| 100 | Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Regueiro M · 2003 · Inflamm Bowel Dis | | 215 |